UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO - Q4 2016 holdings

$34.9 Million is the total value of UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO's 35 reported holdings in Q4 2016. The portfolio turnover from Q3 2016 to Q4 2016 was - .

 Value Shares↓ Weighting
MSFT NewMICROSOFT CORP$1,473,00023,707
+100.0%
4.22%
MBBYF NewMOBILEYE$213,0005,600
+100.0%
0.61%
FFIN NewFIRST FINL BANKSHARES INC$104,0002,300
+100.0%
0.30%
PSX NewPHILLIPS 66$50,000575
+100.0%
0.14%
BWXT NewBWX TECHNOLOGIES$20,000513
+100.0%
0.06%
HAL NewHALLIBURTON CO$18,000324
+100.0%
0.05%
BMY NewBRISTOL-MYERS SQUIBB CO.$16,000268
+100.0%
0.05%
WFC NewWELLS FARGO COMPANY(NEW)$6,000113
+100.0%
0.02%
ALXN NewALEXION PHARMACEUTICALS INC$5,00040
+100.0%
0.01%
HTH NewHILLTOP HOLDINGS INC$5,000173
+100.0%
0.01%
ETP NewENERGY TRANSFER PARTNERS LPlp - public equity$5,000135
+100.0%
0.01%
BW NewBABCOCK & WILCOX$4,000255
+100.0%
0.01%
SON NewSONOCO PRODUCTS INC$4,00085
+100.0%
0.01%
GE NewGENERAL ELECTRIC CO$3,000100
+100.0%
0.01%
YUM NewYUM! BRANDS INC$3,00050
+100.0%
0.01%
SXC NewSUNCOKE ENERGY INC$2,000136
+100.0%
0.01%
VB NewVANGUARD SMALL-CAP ETF$2,00019
+100.0%
0.01%
VZ NewVERIZON COMMUNICATIONS INC$2,00040
+100.0%
0.01%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2017-02-07
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
TEXAS INSTRUMENTS INC44Q2 202431.2%
PORTLAND GENERAL ELECTRIC CO41Q2 20240.0%
LEXICON PHARMACEUTICALS INC36Q2 20241.7%
AEGLEA BIOTHERAPEUTICS INC27Q2 202311.0%
APOLLO ENDOSURGERY INC24Q1 20235.6%
PLX PHARMA INC23Q1 20231.7%
VANGUARD MSCI EMERGING MKTS22Q2 201910.3%
VANGUARD ENERGY ETF22Q2 20198.7%
VANGUARD S&P 500 ETF21Q3 202311.8%
VANGUARD MSCI EAFE ETF20Q2 201913.1%

View UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO's complete holdings history.

Latest significant ownerships (13-D/G)
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO Q4 2016 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
AILERON THERAPEUTICS INCMarch 05, 20241,812,6276.2%
Taysha Gene Therapies, Inc.September 24, 20211,156,2553.0%
ZIOPHARM ONCOLOGY INCFebruary 12, 201690.0%

View UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR/A2024-09-17
N-PX2024-09-03
13F-HR/A2024-08-29
13F-HR/A2024-08-29
13F-HR/A2024-08-29
13F-HR/A2024-08-29
13F-HR/A2024-08-29
13F-HR2024-08-01
42024-06-17
42024-06-12

View UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO's complete filings history.

Compare quarters

Export UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO's holdings